Gene manipulation and cell vaccines represent innovative strategies to enhance the immunogenicity of cancer cells. We adopted a defective lentivirus derived from the human immunodeficiency virus (HIV)-1 backbone and carrying the enhanced green fluorescent protein (EGFP) gene to transduce primary human acute myelogenous leukemia (AML) and B-precursor acute lymphoblastic leukemia (ALL) cells
Biagi, E., Bambacioni, F., Gaipa, G., Casati, C., Golay, J., Biondi, A., et al. (2001). Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells. HAEMATOLOGICA, 86(1), 13-16.
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells
BIAGI, ETTORE;GAIPA, GIUSEPPE;BIONDI, ANDREA;
2001
Abstract
Gene manipulation and cell vaccines represent innovative strategies to enhance the immunogenicity of cancer cells. We adopted a defective lentivirus derived from the human immunodeficiency virus (HIV)-1 backbone and carrying the enhanced green fluorescent protein (EGFP) gene to transduce primary human acute myelogenous leukemia (AML) and B-precursor acute lymphoblastic leukemia (ALL) cells
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
